Life Biosciences

Life Biosciences is a biotechnology company dedicated to discovering and developing novel therapies to improve the lives of people as they age.

Life Biosciences is developing innovative therapies to transform how we treat diseases by targeting aging biology.

Life Biosciences was founded in 2017 by David Sinclair and Tristan Edwards. The company is headquartered in Boston, MA.

 

Life Biosciences is focusing on three platforms targeting key mechanisms underlying aging biology: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming.

 

Life Biosciences is pursuing indication areas where aging biology has a clear link to disease pathogenesis. Life Biosciences prioritizes diseases where there are limited or no available treatment options approved today.

 

Life Biosciences is backed by Alpha Wave Ventures, George Godula, and others. The company closed a $82M Series C round on Jan 05, 2022. This brings Life Biosciences' total funding to $206.8M to date.

 

 

 

  • Year founded: 2017
  • Funding Info: $206.8M over 3 Rounds (Latest Funding Type: Series C)
  • Yearly Revenue: NA
  • Employee Size: 11-50
  • Business Valuation: NA
  • City/Town: Boston
  • State: Massachusetts
  • Country: United States
Related businesses